Immune Boost Capital Appoints Dr. Sai Nandi to Head Impact Investment Fund Targeting Immune-Mediated Diseases
Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for immune disorders. Immune Boost Capital (IBC), the newly formed venture fund of the Arthritis National Research Foundation (ANRF), today announced that Dr. Sai Nandi has joined the firm as Fund Principal. In this capacity, Dr. Nandi will lead the expansion of […]
60 Minutes to Save Millions
This year, more scientists applied for arthritis and autoimmune disease research funding than at any point in the Arthritis National Research Foundation’s 50-year history. It means that right now, more brilliant early-career researchers are ready to pursue ideas that could change what it means to live with these conditions, affecting more than 60 million adults […]
Arthritis National Research Foundation Appoints Schalon Newton, DBA, as Principal of Immune Boost Capital
Industry Veteran to Lead New Philanthropic Venture Fund Addressing Critical Early-Stage Funding Gap in Autoimmune Therapeutics and Diagnostics The Arthritis National Research Foundation (ANRF), a leading nonprofit funder of early-stage autoimmune disease research, announced the appointment of Schalon Newton, DBA, as Principal of Immune Boost Capital (IBC), its newly formed philanthropic evergreen venture fund. IBC […]
ANRF at ACR Convergence 2025
Each year, the Arthritis National Research Foundation (ANRF) looks forward to joining the global rheumatology community at ACR Convergence, the American College of Rheumatology’s annual meeting taking place this year October 24–29 in Chicago, Illinois. As the world’s leading rheumatology gathering, ACR Convergence brings together scientists, clinicians, and advocates dedicated to improving lives through research, […]
Arthritis National Research Foundation Launches Immune Boost Capital to Accelerate Early-Stage Autoimmune Innovation
New 501(c)(3) Subsidiary Will Provide Philanthropic Venture Capital for Proof-of-Concept Autoimmune Therapies and Diagnostics The Arthritis National Research Foundation (ANRF), a leading funder of early-stage autoimmune disease research, is proud to announce the formation of Immune Boost Capital (IBC), a wholly owned 501(c)(3) subsidiary created to address a growing gap in therapeutic innovation. IBC is […]
Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems
Vie Ventures welcomes additional strategic collaborators, expanding the coalition to morethan ten leading disease philanthropies focused on autoimmune and inflammatory disease Vie Ventures, a new life sciences investment firm focused on bridging venture capital and disease philanthropy to develop breakthrough therapies for patients, today announced the successful convening of its inaugural Therapeutics Advisory Council (TAC). […]